Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated
- 1 March 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (6) , 816-822
- https://doi.org/10.1038/sj.bjp.0707126
Abstract
Background and purpose: Adenosine suppresses immune responses through adenosine2A(A2A) receptors, by raising intracellular cAMP. Interleukin (IL)‐18 up‐regulates the expression of intercellular adhesion molecule (ICAM)‐1 on monocytes, leading to production of pro‐inflammatory cytokines such as IL‐12, interferon (IFN)‐γand tumor necrosis factor (TNF)‐αby human peripheral blood mononuclear cells (PBMC). We have previously demonstrated that elevation of cAMP inhibits this IL‐18‐induced expression of adhesion molecules. In the present study, we examined the effect of adenosine on the IL‐18‐induced up‐regulation of ICAM‐1 on human monocytes and production of IL‐12, IFN‐γand TNF‐αby PBMC.Experimental approach: The expression of ICAM‐1 was examined by flow cytometry. IL‐12, IFN‐γand TNF‐αwere determined by ELISA assay.Key results: Adenosine inhibited the IL‐18‐induced up‐regulation of ICAM‐1 on human monocytes and it abolished the IL‐18‐enhanced production of IL‐12, IFN‐γand TNF‐α. While an A2Areceptor antagonist reversed the action of adenosine, an A1or A3receptor antagonist enhanced them. An A2Areceptor agonist, CGS21680, mimicked the effects of adenosine and its effects were abolished not only by the A2Areceptor antagonist but also by A1or A3receptor agonists. Activation via A2Areceptors resulted in elevation of cAMP in monocytes, whereas the stimulation of A1or A3receptors inhibited it, suggesting that intracellular signal transduction following ligation of A2Areceptors might be blocked by activation of A1or A3receptors.Conclusions and Implications: Adenosine differentially regulates IL‐18‐induced adhesion molecule expression and cytokine production through several subtypes of its receptors.British Journal of Pharmacology(2007)150, 816–822. doi:10.1038/sj.bjp.0707126Keywords
This publication has 25 references indexed in Scilit:
- Agents against cytokine synthesis or receptorsEuropean Journal of Pharmacology, 2006
- Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung InjuryPLoS Biology, 2005
- Protection from ischemic liver injury by activation of A2Aadenosine receptors during reperfusion: inhibition of chemokine inductionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Unique Regulation Profile of Prostaglandin E1 on Adhesion Molecule Expression and Cytokine Production in Human Peripheral Blood Mononuclear CellsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Research applications and implications of adenosine in diseased airwaysTrends in Pharmacological Sciences, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.Journal of Clinical Investigation, 1998
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Inhibition of human monocyte TNF production by adenosine receptor agonistsLife Sciences, 1993